FyoniBio is a trusted brand in the biopharmaceutical industry with nearly 20 years of experience in development. We specialize in providing tailor-made services at various stages of drug development. Our ISO 9001:2015 certified biopharmaceutical services are designed to ensure customer satisfaction, offering high efficiency and competitive timelines.

At FyoniBio, we excel in cell line development, process development, mass spectrometry, clinical bioanalysis, and analytical services & bioassays. Our unique portfolio includes the CHOnamite® platform, consisting of CHO-K1 and CHO-DG44 cell lines, as well as our proprietary GlycoExpress® (GEX®) technology. These advanced tools allow us to compare glycoprotein projects, ensuring the utmost productivity and quality.

Our team is committed to transparency at every stage of the development process, with dedicated project management. We offer fast track and low-cost feasibility studies to identify the ideal starting cell line. Our upstream process development utilizes mammalian cell culture systems to determine the most optimal production mode.

In parallel, our downstream process development incorporates the latest methodologies for a robust and regulatory compliant process. To support cell line and process development, we provide mass spectrometry-based glycan and protein analytics. Additionally, our clinical bioanalysis group offers a wide range of assays to analyze blood/serum samples from patients.

Partner with FyoniBio and experience our comprehensive and personalized biopharmaceutical services for your drug development needs. Get in touch with us today for more information